Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2020-09-14

Original market date: See footnote 1

2005-12-15

Product name:

TRELSTAR

Description:

MICROGRANULES FOR DEPOT SUSP. 3 MONTH SLOW-RELEASE

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

02243856

Product Monograph/Veterinary Labelling:

Date: 2021-01-25 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

KNIGHT THERAPEUTICS INC.
1055  3400 De Maisonneuve Blvd W
Montreal
Quebec
Canada  H3Z 3B8

Class: 

Human

Dosage form(s):

Powder For Suspension, Sustained-Release

Route(s) of administration:

Intramuscular

Number of active ingredient(s):

1

Schedule(s):

Prescription  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

10:00.00   ANTINEOPLASTIC AGENTS

Anatomical Therapeutic Chemical (ATC): See footnote 4

L02AE04  TRIPTORELIN

Active ingredient group (AIG) number:See footnote 5

0137103002

List of active ingredient(s)
Active ingredient(s) Strength
TRIPTORELIN (TRIPTORELIN PAMOATE) 11.25 MG / VIAL

Application information

Related information

Contact us

Version 3.9.0
Date modified: